661 Dipeptidyl peptidase-9 (DPP9) overexpression is a potential response-predictive biomarker of BXCL701 and pembrolizumab combination treatment in mCRPC patients with SCNC phenotype
Donkor, Moses K, Agarwal, Veena, Kupchick, Sherry, Deshpande, Rashmi, Newmin, Dawn, O’Neill, Vincent
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article